Author： van Giersbergen P.L.M. Gnerre C. Treiber A. Dingemanse J. Meyer U.A.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.450, Iss.2, 2002-08, pp. : 115-121
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bosentan: a dual endothelin receptor antagonist
By Roux Sébastien Rubin Lewis J
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. :
Access to resources
Recommend
By Kefford Richard Beith Jane Hazel Guy Millward Michael Trotter James Wyld David Kusic Rada Shreeniwas Revati Morganti Adele Ballmer Andrea Segal Eleonor Nayler Oliver Clozel Martine
Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. :
The endothelin receptor antagonist bosentan [`Tracleer'; Actelion] has been approved in Canada
Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. :